+62.6%
GSK vs ALLE
+88.9%
-26.3%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ALLE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -0.9% | +0.8% | 0.0% |
| 7D | +1.7% | -0.6% | +2.2% | +1.8% |
| 30D | +7.0% | +25.3% | -18.3% | +2.3% |
| 3M | -2.7% | +10.3% | -12.9% | -4.6% |
| 6M | +1.4% | +38.0% | -36.6% | -5.3% |
| YTD | +5.3% | +17.8% | -12.4% | +1.0% |
| 1Y | +10.6% | +13.6% | -3.0% | +6.9% |
| 3Y | +62.6% | +89.2% | -26.6% | +43.8% |
| All | +62.6% | +88.9% | -26.3% | +43.8% |
Cumulative growth
Daily Returns
Daily percentage return beside ALLE.
Daily Out/Under-Performance
Portfolio return minus ALLE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALLE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ALLE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling